Please login to the form below

Not currently logged in
Email:
Password:

US Congress

This page shows the latest US Congress news and features for those working in and with pharma, biotech and healthcare.

Pfizer, Sanofi and others set to increase US drug prices in 2021

Pfizer, Sanofi and others set to increase US drug prices in 2021

Drug pricing will also be a focus of the incoming President-elect, Joe Biden, who has promised to reduce drug prices in the US. ... Despite the ongoing debate around drug pricing in the US Congress, it is expected that further drug price increases are to

Latest news

  • US start-up EQRx promises approach that will slash drug prices US start-up EQRx promises approach that will slash drug prices

    A new US start-up says it has a plan to completely revamp the approach to drug development, allowing to launch drugs more quickly and at a lower cost. ... Bach recently  proposed a model for selecting drugs for pricing negotiations with Medicare – a

  • It's the guns, stupid It's the guns, stupid

    Gun violence in the US – a public health issue – can be better understood through three points. ... The first one is actually simpler to answer. In 1996, the US congress passed the Dickey Amendment which was, effectively, a response to the Centers

  • Roche says ‘discovery proteomics’ is heading for clinical trials Roche says ‘discovery proteomics’ is heading for clinical trials

    A study presented at the Mass Spectrometry Applications to the Clinical Lab (MSACL) congress in the US last week by Roche and Biognosys scientists looked at how ‘discovery proteomics’ performed in

  • GSK to reverse ‘no KOLs’ policy, admitting it has hit marketing GSK to reverse ‘no KOLs’ policy, admitting it has hit marketing

    This included a $3bn fine imposed on GSK after it was caught promoting Advair off-label in the US, with a corporate integrity agreement imposed on it by US regulators. ... It will also return to paying travel costs for HCPs to attend GSK’s own

  • FDA moves to tackle orphan designation backlog FDA moves to tackle orphan designation backlog

    The US regulator's Orphan Drug Modernisation Plan aims to eliminate the waiting list, and is the first development under the FDA's new Medical Innovation Development Plan. ... Congress gave us tools to incentivise the development of novel therapies for

More from news
Approximately 1 fully matching, plus 29 partially matching documents found.

Latest Intelligence

  • Rethinking our approach to infectious disease preparedness Rethinking our approach to infectious disease preparedness

    Achaogen and Aradigm filed for bankruptcy in 2019, and Melinta did the same at the start of 2020, despite heavy investment from the US Biomedical Advanced Research and Development Authority (BARDA). ... The same approach is currently proposed in a bill

  • Facing up to virtual reality Facing up to virtual reality

    One option is to completely reconfigure the congress model – by thinking about time in a different way. ... What’s more, when the pandemic is behind us, congress communities are unlikely to walk back on the progress they’ve made or the mindset

  • The global antibiotic crisis: a 2020 perspective The global antibiotic crisis: a 2020 perspective

    A much-talked-about initiative in the United States is the Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act which advocates hope to get through the US Congress in ... July 2019 saw us take forward an anti-

  • Attracting doctors to low-demand specialties Attracting doctors to low-demand specialties

    A US survey that has been undertaken every year since the early 1990s provides some illumination as to the specialties that residents and fellows completing their training in New York State ... A brief glance at the programme for the major US haematology

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • OPEN Health’s virtual reflections on the World Orphan Drug Congress US OPEN Health’s virtual reflections on the World Orphan Drug Congress US

    Another congress attended in this virtual world with learnings gathered and connections made across the rare disease community. ... In conclusion, this congress has ‘US’ tagged to its name but it is very clear from the dialogue that we face Global

  • OPEN Health OPEN Health

    We asked Becca McConnell to give us an insight into her role as Senior Account Executive at OPEN Health. ... OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa.

  • Attracting doctors to low-demand specialties: A role for industry?

    A US survey that has been undertaken every year since the early 1990s provides some illumination as to the specialties that residents and fellows completing their training in New York State ... A brief glance at the programme for the major US haematology

  • EULAR Annual European Congress of Rheumatology 2017

    Join us at EULAR Congress 2017 in Madrid, 14-17 June. We are delighted to be attending and presenting at this year’s EULAR Annual European Congress of Rheumatology in June.

  • Research Partnership

    Research Partnership is today expanding its US operations across both the West and East Coast. ... Visit us on stand number 14. Join us at EULAR Congress 2017 in Madrid, 14-17 June.

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics